Unaudited Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2022	$ 320,740	$ 42	$ 432,703	$ (1,535)	$ (110,470)
Beginning balance (in shares) at Dec. 31, 2022		41,616,260
Exercise of common stock options	1,580		1,580
Exercise of common stock options (in shares)		148,649
Shares issued under employee stock purchase plan	528		528
Shares issued under employee stock purchase plan (in shares)		57,911
Vesting of restricted shares	139		139
Vesting of restricted shares (in shares)		44,716
Stock-based compensation	10,974		10,974
Unrealized gain (loss) on available-for-sale securities, net	475			475
Net loss	(34,967)				(34,967)
Ending balance at Jun. 30, 2023	299,469	$ 42	445,924	(1,060)	(145,437)
Ending balance (in shares) at Jun. 30, 2023		41,867,536
Beginning balance at Mar. 31, 2023	311,264	$ 42	439,890	(739)	(127,929)
Beginning balance (in shares) at Mar. 31, 2023		41,802,807
Shares issued under employee stock purchase plan	528		528
Shares issued under employee stock purchase plan (in shares)		57,911
Vesting of restricted shares	5		5
Vesting of restricted shares (in shares)		6,818
Stock-based compensation	5,501		5,501
Unrealized gain (loss) on available-for-sale securities, net	(321)			(321)
Net loss	(17,508)				(17,508)
Ending balance at Jun. 30, 2023	299,469	$ 42	445,924	(1,060)	(145,437)
Ending balance (in shares) at Jun. 30, 2023		41,867,536
Beginning balance at Dec. 31, 2023	344,349	$ 46	512,401	665	(168,763)
Beginning balance (in shares) at Dec. 31, 2023		46,252,440
Issuance of common stock and pre-funded common stock warrants, net of issuance costs	320,059	$ 5	320,054
Issuance of common stock and pre-funded common stock warrants, net of issuance costs (in shares)		5,397,301
Exercise of common stock options	$ 4,404	$ 1	4,403
Exercise of common stock options (in shares)	441,368	441,368
Shares issued under employee stock purchase plan	$ 473		473
Shares issued under employee stock purchase plan (in shares)		63,070
Vesting of restricted shares	10		10
Vesting of restricted shares (in shares)		8,036
Stock-based compensation	11,382		11,382
Unrealized gain (loss) on available-for-sale securities, net	(2,281)			(2,281)
Net loss	(20,719)				(20,719)
Ending balance at Jun. 30, 2024	657,677	$ 52	848,723	(1,616)	(189,482)
Ending balance (in shares) at Jun. 30, 2024		52,162,215
Beginning balance at Mar. 31, 2024	655,763	$ 51	839,759	(524)	(183,523)
Beginning balance (in shares) at Mar. 31, 2024		51,840,571
Issuance costs	(17)		(17)
Exercise of common stock options	2,747	$ 1	2,746
Exercise of common stock options (in shares)		255,086
Shares issued under employee stock purchase plan	473		473
Shares issued under employee stock purchase plan (in shares)		63,070
Vesting of restricted shares	5		5
Vesting of restricted shares (in shares)		3,488
Stock-based compensation	5,757		5,757
Unrealized gain (loss) on available-for-sale securities, net	(1,092)			(1,092)
Net loss	(5,959)				(5,959)
Ending balance at Jun. 30, 2024	$ 657,677	$ 52	$ 848,723	$ (1,616)	$ (189,482)
Ending balance (in shares) at Jun. 30, 2024		52,162,215